These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1100727)

  • 1. The immune adherence receptor: dissociation between the expression of erythrocyte and mononuclear cell C3b receptors.
    Rothman IK; Gelfand JA; Fauci AS; Frank MM
    J Immunol; 1975 Nov; 115(5):1312-5. PubMed ID: 1100727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface markers of complement receptor lymphocytes.
    Ross GD; Winchester RJ; Rabellino EM; Hoffman T
    J Clin Invest; 1978 Nov; 62(5):1086-92. PubMed ID: 711854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on immune adherence (C3b) receptor activity of human erythrocytes: relationship between receptor activity and presence of immune complexes in serum.
    Inada Y; Kamiyama M; Kanemitsu T; Hyman CL; Clark WS
    Clin Exp Immunol; 1982 Oct; 50(1):189-97. PubMed ID: 6216998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of the presence of membrane receptors for complement, IgG and the sheep erythrocyte rosetting capacity on the same human lymphocytes.
    Chiao JW; Good RA
    Eur J Immunol; 1976 Mar; 6(3):157-62. PubMed ID: 991902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptors for immunoglobulin and complement on human alveolar macrophages.
    Reynolds HY; Atkinson JP; Newball HH; Frank MM
    J Immunol; 1975 Jun; 114(6):1813-9. PubMed ID: 1127229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of human lymphocytes with fluid phase human C3b detected by immunofluorescence.
    Simonian S; Molenaar JL; Zeijlemaker WP; Knape JT; Bakker S; Pondman KW
    Eur J Immunol; 1976 Jan; 6(1):52-6. PubMed ID: 823035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative pathway of complement activation by stimulated T lymphocytes. II. Elevation of cytotoxic potential against complement receptor-carrying cell lines.
    Ramos OF; Sármay G; Eggertsen G; Nilsson B; Klein E; Gergely J
    Eur J Immunol; 1987 Jul; 17(7):975-9. PubMed ID: 3111863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.
    Wåhlin B; Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
    J Immunol; 1983 Jun; 130(6):2831-6. PubMed ID: 6222118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor-binding sites on C3 and C3b.
    Dierich MP; Bokisch VA
    J Immunol; 1977 Jun; 118(6):2145-50. PubMed ID: 864256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xenoantiserum to human C3 receptors: its preparation and effect on the C3b and C3d receptors of tonsil cells and the C3b receptors of erythrocytes and neutrophils.
    Gerdes J; Klatt U; Stein H
    Immunology; 1980 Jan; 39(1):75-84. PubMed ID: 6991397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation on discontinuous gradients of bovine albumin of a subpopulation of human lymphocytes exhibiting precursor characteristics.
    Gatien JG; Schneeberger EE; Parkman R; Merler E
    Eur J Immunol; 1975 May; 5(5):306-12. PubMed ID: 135685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reaction of an activated complex of guinea-pig complement components, C56, with unsensitized erythrocytes and with erythrocytes carrying C3b molecule.
    Tamura N; Baba AS
    Immunology; 1976 Jul; 31(1):151-8. PubMed ID: 1027719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Native C3 does not bind to the C3b receptor (CR1) of human blood B lymphocytes or alter immunoglobulin synthesis.
    Berger M; Fleisher TA
    J Immunol; 1983 Mar; 130(3):1021-3. PubMed ID: 6600466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human lymphocytes bear membrane receptors for C3b and C3d.
    Eden A; Miller GW; Nussenzweig V
    J Clin Invest; 1973 Dec; 52(12):3239-42. PubMed ID: 4543024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the in vivo effects of antibody. Interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man.
    Atkinson JP; Frank MM
    J Clin Invest; 1974 Aug; 54(2):339-48. PubMed ID: 4847248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of complement in adherent immune complexes on Fc and C3 receptor expression in human monocytes.
    Arend WP; Massoni RJ
    Immunology; 1981 Dec; 44(4):717-25. PubMed ID: 7319557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of C-reactive protein with lymphocytes and monocytes: complement-dependent adherence and phagocytosis.
    Mortensen RF; Osmand AP; Lint TF; Gewurz H
    J Immunol; 1976 Sep; 117(3):774-81. PubMed ID: 60448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition by C3 fragments of C3-dependent rosette formation and antigen-induced lymphocyte transformation.
    Pepys MB; Butterworth AE
    Clin Exp Immunol; 1974 Oct; 18(2):273-82. PubMed ID: 4619599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of complement activation by cobra venom factor on the migration of T and B lymphocytes into rat thoracic duct lymph.
    Spry CJ; Lane JT; Vyakarnam A
    Immunology; 1977 Jun; 32(6):947-54. PubMed ID: 301855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptors for IgG and complement in human spleen lymphoid cells. Preferential binding of particulate immune complexes through complement receptors.
    Scornik JC; Drewinko B
    J Immunol; 1975 Nov; 115(5):1223-6. PubMed ID: 1176774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.